Elmidor, Nenialyn .

HRN: 04-89-22  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/01/2025
CLINDAMYCIN 150MG/ML, 4ML (AMP)
02/01/2025
02/08/2025
IV
600mg
Q8h
T/C Pox Disease
Waiting Final Action 
02/02/2025
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
02/02/2025
02/09/2025
IV
4.5 Grams
Q8h
Bacterial Skin Infection
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: